End-Stage Heart Failure

Introduction

End-stage heart failure (HF) is the most advanced phase of heart failure, where the heart is no longer able to pump blood effectively to meet the body's needs, even with optimal medical treatment. At this stage, symptoms become severe and significantly impact the patient’s quality of life.

Causes and Risk Factors

End-stage heart failure is often the result of long-term conditions that progressively weaken the heart, such as: - Coronary artery disease (CAD) – Blockages in the heart’s blood vessels reduce oxygen supply to the heart muscle, leading to damage over time. - Hypertension (high blood pressure) – Increases the workload on the heart, eventually causing heart muscle weakening. - Previous heart attacks (myocardial infarction) – Damage to the heart muscle reduces its pumping ability. - Cardiomyopathies and genetic conditions – Diseases that directly affect heart muscle function. - Valvular heart disease – Problems with heart valves can lead to inefficient blood flow. - Diabetes and kidney disease – Contribute to overall cardiovascular deterioration.

Symptoms of End-Stage Heart Failure

Patients experience severe symptoms, including: - Extreme shortness of breath (even at rest) - Frequent hospitalizations due to worsening heart failure - Severe fluid retention (swelling in legs, abdomen, and lungs) - Fatigue and weakness - Cognitive dysfunction and confusion due to reduced oxygen supply to the brain - Marked intolerance to physical activity

Diagnostic Evaluation

To assess end-stage heart failure, doctors use: - Echocardiography – To assess heart function and ejection fraction. - BNP/NT-proBNP blood tests – Indicate heart failure severity. - Cardiac MRI or CT scan – To evaluate structural details of the heart. - Right heart catheterization – Measures heart pressures to assess severity. - Electrocardiography (ECG) – Detects arrhythmias or conduction issues.

Treatment Strategies

1. Medications

  • Diuretics – Reduce fluid overload and ease breathing.
  • Beta-blockers – Help control heart rate and protect the heart from excessive strain.
  • ACE inhibitors/ARBs/ARNIs – Improve survival by reducing the heart's workload.
  • Aldosterone antagonists – Help in fluid management.
  • Inotropes (e.g., Milrinone, Dobutamine) – Assist in maintaining perfusion in refractory cases.

2. Advanced Therapies

  • Implantable Cardioverter-Defibrillator (ICD) – Protects against life-threatening arrhythmias.
  • Cardiac Resynchronization Therapy (CRT) – Improves heart function in selected patients.
  • Left Ventricular Assist Devices (LVADs) – Mechanical pumps that support heart function in patients awaiting transplant or as destination therapy.
  • Heart Transplantation – The most definitive treatment for end-stage heart failure, indicated in eligible patients.

3. Palliative and Supportive Care

  • Focuses on symptom relief and quality of life improvement.
  • Hospice care may be considered when advanced interventions are not an option.

Prognosis

End-stage heart failure has a poor prognosis, with a high risk of hospitalization and mortality. However, with appropriate medical and advanced treatments, survival and quality of life can improve.

Conclusion

End-stage heart failure requires specialized care that includes medical therapy, device-based strategies, possibly heart transplantation, or palliative approaches. Close collaboration between cardiologists, heart failure specialists, and supportive care teams is crucial.

Source recommendations

1. American Heart Association Guidelines for the Management of Heart Failure

  1. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
  2. https://professional.heart.org/en/guidelines-and-statements
  3. https://www.heart.org/en/health-topics/heart-failure
  4. https://professional.heart.org/en/science-news/-/media/832EA0F4E73948848612F228F7FA2D35.ashx
  5. https://www.heart.org/en/health-topics/heart-failure/treatment-options-for-heart-failure

2. European Society of Cardiology Guidelines on Heart Failure

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
  2. https://academic.oup.com/eurheartj/article/42/36/3599/6358045
  3. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Focused-Update-on-Heart-Failure-Guidelines
  4. https://academic.oup.com/eurheartj/article/44/37/3627/7246292
  5. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow